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BACKGROUND: Human immunodeficiency virus type 1 (HIV-1)–seropositive patients are at a high risk 
for the development of a variety of acute and chronic renal diseases. Most patients with HIVAN are of 
African descent, presenting late in the course of their HIV-1 infection. The only reliable test to establish 
or rule out the presence of HIVAN (HIV associated nephropathy) is renal biopsy. The most common 
lesion associated with HIV is a focal segmental glomeruloscelerosis, but several times, other biopsy 
findings may also be seen. Our patient had lupus nephritis like pathology picture. The therapeutic agents 
with the most promise are angiotensin-converting enzyme inhibitors and antiretroviral medications. Role 
of steroids are less well-defined although they have been used with success many times.   
CASE DETAILS: Our patient was a young male who presented with a pulmonary renal syndrome like 
picture and wasting. On evaluation, he was found to be HIV-1 positive, and renal biopsy showed lupus 
nephritis like pathological picture. The patient was treated with HAART (Highly active anti retroviral 
therapy) , steroids and ACE inhibitors and showed an excellent response. 
CONCLUSION: The case highlights the fact that immune mediated glomerulonephritis, although rare, 
can be the presenting feature of HIV infection and can be controlled, if not cured, with proper treatment. 
KEYWORDS: HIV, Glomerulonephritis, HIV associated nephropathy  
 
DOI:  http://dx.doi.org/10.4314/ejhs.v24i3.13 
INTRODUCTION  
The association between HIV (Human 
Immunodeficiency Virus) and renal disease was 
first reported in 1984 by investigators in New 
York City and Miami. They reported a series of 
HIV-1–seropositive patients who developed a 
renal syndrome characterized by progressive renal 
failure and proteinuria (1). The most common 
kidney biopsy finding was focal segmental 
glomerulosclerosis (FSGS) (2). During the next 
several years, the existence of a specific HIV 
associated nephropathy (HIVAN) was debated, in 
part, because of its similarity with heroin 
nephropathy and the frequent occurrence of 
intravenous drug use in this population (4). The 
study by Wearne and colleagues in 2011, which 
included the largest group of patients of African 
ancestry with HIVAN studied so far, describes 
renal histological variants of HIVAN, and 
suggests that antiretroviral therapies improve the 
clinical outcome of all HIV-associated renal 
diseases. They could identify only 9 cases of 
immune complex glomerulopathy of the 221 
biopsies studied.We present a case of a young 
Asian male with HIV associated nephropathy with 
rare lesion of immune mediated proliferative 
glomerulonephritis who responded to steroids, 
HAART (Highly Active Antiretroviral Therapy) 
and ACE inhibitors (angiotensin-converting-
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A 25 years old male from the Kargil area of North 
India presented with cough, expectoration and 
pedal edema of one month duration. There was 
associated high grade fever and minimal 
hemoptysis. Also, there was a history of chronic 
diarrhea in the form of passage of watery loose 
stools 3 to 4 times daily for one year. The patient 
had a significant weight loss. On examination 
patient was found to be emaciated with a body 
mass index of 16.There was mild pedal edema. 
There was no hypertention. Chest examination 
revealed crepiations and bronchial breathing in the 
left mammary area.  
Chest X-ray showed a left upper and mid 
zone consolidation. HRCT chest showed patchy 
cavitary consolidation of the upper lobe of left 
lung. Urine examination showed an active 
sediment and 24 hours urinary examination 
revealed nephrotic range proteinuria (4gm/24 hrs). 
The patient dropped his urine output and the 
serum creatinine was worsening from the initial of 
1.1 to 3.2. A renal biopsy was planned which 
showed immune  mediated proliferative  
glomerulonephritis (mesangial and endocapillary 
proliferation) with crescents in 33 percent of the 
glomeruli examined exhibiting segmentally 
thickened  capillary walls (with double contours) 
and nodular mesangial expansion with presence of 
subendothelial and mesangial non congophilic , 
non argyrophyllic , fuchsinophilic deposits. Direct 
Immunofluoresence of the same revealed capillary 
wall and mesangial deposits of immunoglobulins 
(Ig G, Ig M) and complement product C3.  With 
this histopathologic and clinical picture the patient 
was evaluated for a possible pulmonary renal 
syndrome. Simultaneously, the patient was put on 
treatment for community acquired pneumonia 
with ceftriaxone and azithromycin. Work up for 
all the pulmonary renal syndromes proved to be 
negative with negative ANCA, anti GBM. Also, as 
the renal biopsy features favored lupus nephritis 
like picture, ANA, anti dsDNA, anti smith 
antibodies, were sought but all were negative. 
Further, the patient’s clinical profile was also 
against the diagnosis of systemic lupus nephritis. 
Tubercular work up (mantoux test, sputum for 
acid fast bacilli, sputum culture, urine for acid fast 
bacilli) was negative. Stool examination also did 
not help the diagnosis as it showed only non-
specific inflammatory cells and no organism of 
significance could be grown. Hemogram showed 
pancytopenia. It was at this time the patient’s 
kidney function further deteriorated and was put 
on pulse steroids emperically (1g 
of methylprednisolone intravenously given daily, 
for three days) which did help in recovering the 
kidney function. In view of chronic diarrhea, 
emaciation , and the high risk sexual behavior 
(heterosexual) an ELISA was done for anti-HIV 
(Human immunodeficiency virus) antibodies 
which was positive for HIV-1 and was confirmed 
with western blot. CD4 cell count was found to be 
175 and HIV viral load was 100,000 copies per 
ml. Virological screening for hepatitis B and C 
viruses was negative.   
 
 
Figure 1: A histopathological picture showing 
mesangial and endocapillary glomerulonephritis 
 
 
Figure 2: HRCT chest showing a left upper lobe   
consolidation    
 




With this history, examination and investigations a 
final diagnosis of HIV AIDS (Acquired 
Immunodeficiency Syndrome), HIV associated 
nephropathy, HIV associated pancytopenia and 
community acquired pneumonia was made. 
Treatment was initiated with highly active anti-
retroviral therapy [HAART; elvitegravir (150 mg) 
+ cobicistat (150 mg) + emtricitabine (200 mg) + 
tenofovir (300 mg) qd].Oral steroids were also 
prescribed(prednisone 60 mg qd for 1 month and 
subsequently tapered) as the patient had initially 
shown a good response to steroids. ACE inhibitors 
were introduced once the renal parameters had 
stabilized after around 4 to 5 weeks. Antibiotics 
were given for a total of 14 days after which there 
was clinical improvement in chest signs and 
symptoms. Subsequently, cryptosporidium was 
isolated in the stools of the patient, and the patient 
was put on a lactose free diet. Nutritional 
supplement with zinc and glutamine was given. 
Nitazoxanide PO 500 mg every 12 hour for 3 days 
was given along with HAART.As in the case with 
most HIV cryptosporidiosis, the diarrhea 
responded only after HAART had started to act, 
after around one month.  
At 12 months follow-up the patient improved 
significantly. HIV viral load is less than 500 per 
ml, the proteinuria is minimal, the chronic 
diarrhea has been treated, the patient has 
significant weight gain and CD4 count is 650. 
 
                               
 
 
       
                   Figure 3: Image of the patient showing the emaciated appearance before the treatment































In the past 18 years since HIVAN was first 
described, much has been published regarding the 
epidemiology, pathogenesis, and treatment of this 
disease. Despite these advances, however, HIVAN 
continues to be a serious cause of renal failure in the 
United States and other countries with large 
populations of African descent (2). HIV associated 
nephropathy (HIVAN) is usually diagnosed in 
patients who have been HIV-1–seropositive for 
several years and most patients have low CD4 counts 
and/or other criteria for the diagnosis of AIDS (4). In 
the post– highly active antiretroviral therapy 
(HAART) era, however, more patients are being 
identified who present earlier in the course of HIV 
infection with CD4 counts above 200 (5). HIVAN is 
often characterized clinically by the presence of 
proteinuria, but not necessarily in the nephrotic 
range (6, 7). Most patients have moderate to severe 
renal insufficiency at the time of diagnosis (2), 
although a cohort of patients with HIVAN and mild 
renal insufficiency has been recently described 
(6).Several types of renal disease seem to be directly 
or indirectly caused by HIV: classic HIVAN, HIV-
associated thrombotic microangiopathy, and HIV-
associated, immune-mediated glomerulonephritides. 
Classic HIVAN is a syndrome caused by focal 
sclerosing glomerulopathy with severe proteinuria, 
renal failure, and rapid progression to ESRD. It has 




become the most common cause of ESRD in HIV-1–
seropositive patients. HIVAN primarily occurs in 
patients of African descent (8), suggesting a genetic 
predisposition to the disease. Duffy antigen/receptor 
for chemokines has been controversially discussed as 
a candidate gene involved in the development of 
HIVAN (9). 
The estimated prevalence of HIVAN has 
ranged from 3.5% in clinical studies to 12% in 
autopsy studies (10). Because HIVAN typically 
occurs late in the course of HIV-1 infection, risk 
factors for the development of HIVAN include a 
CD4 cell count <200 cells/mm
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 and a high viral 
burden. Clinical features of this syndrome include 
advanced renal failure and proteinuria (the protein 
level is often-but not necessarily-at a nephrotic level, 
a lack of peripheral edema despite the severe loss of 
protein, and, frequently, enlarged kidneys visible on 
renal ultrasound. Renal biopsy is the only means to 
establish the diagnosis of HIVAN. Characteristic 
histological findings include collapsing focal and 
segmental glomerulosclerosis, tubular epithelial 
atrophy with microcystic dilatation of the tubules, 
and lymphocytic interstitial infiltration. Viral 
infection of renal cells seems to play an important 
role in the pathogenesis of HIVAN (10). 
Thrombotic microangiopathy: Thrombotic 
microangiopathy, hemolytic uremic syndrome, and 
thrombotic thrombocytopenic purpura present a 
spectrum of diseases characterized by haemolytic 
anemia, thrombocytopenia, and renal insufficiency 
and clinical features such as fever and neurological 
manifestations. Several reports have linked 
thrombotic microangiopathy HIV infection, 
suggesting that HIV proteins may mediate 
endothelial dysfunction, leading to platelet 
deposition in the microvasculature (11). 
Immune complex–mediated 
glomerulonephritis: A multitude of immune 
complex-mediated glomerulonephritides have been 
reported as causes of chronic kidney disease in HIV 
infected patients. The prevalence of HIV-associated, 
immune complex–mediated glomerulonephritides 
has been estimated to be 15%–80% (10). A study of 
60 biopsy specimens found that some form of 
immune complex–mediated glomerulonephritis was 
present in 37% of biopsy specimens, sometimes 
concordant with HIVAN-like changes. The findings 
have been into 4 categories: immune complex–
mediated glomerulonephritis, IgA nephritis, mixed 
sclerotic/inflammatory disease and lupus-like 
syndrome (12). Immune complex–mediated 
glomerulonephritis may present as postinfectious 
glomerulonephritis, membranous nephritis, IgA 
nephritis, fibrillary glomerulonephritis, 
immunotactoid glomerulopathy, and 
membanoproliferative glomerulonephritis (13). IgA 
nephritis seems to be more prevalent among 
European patients, with mesangial IgA deposits 
being detected in 7.75% of all HIV-infected patients 
in a postmortem study (14). A recent report 
estimated that the prevalence of lupus-like nephritis, 
characterized by immunoglobulin (IgG, IgA, and 
IgM) and complement (C3 and C1q) deposits, in the 
absence of serologic markers for systemic lupus 
erythematodes, was 17% (10). IgA nephritis seems 
to be more prevalent among European patients, with 
mesangial IgA deposits being detected in 7.75% of 
all HIV-infected patients in a postmortem study (14). 
A recent report estimated that the prevalence of 
lupus-like nephritis, characterized by 
immunoglobulin (IgG, IgA, and IgM) and 
complement (C3 and C1q) deposits, in the absence 
of serologic markers for systemic lupus 
erythematodes, was 17% (15).  Our patient, an 
Asian, was a case HIVAN of immune mediated 
glomerulonephritis with immune deposits of Ig G, Ig 
M and C3 complement product.  
Patients with HIV-associated, immune 
complex–mediated glomerulonephrits seem to 
benefit from treatment with angiotensin-converting 
enzyme inhibitors, glucocorticoids and 
antiretrovirals (16, 17). Our patient was also 
managed with steroids, ACE inhibitors, HAART to 
which he showed promising response. 
Wearne et al. in a study of 221 HIV-positive 
renal biopsies found a spectrum of renal histologies 
of which HIV-associated nephropathy (HIVAN) was 
the most common histology. Combined anti-
retroviral therapy reduced the mortality in those with 
any feature of HIVAN by 57% (18). They identified 
HIVAN plus immune complex GN (HIVAN plus 
ICGN) in nine biopsies which had immune complex 
deposition with a ‘ball-in-cup’ appearance. In all of 
these cases, there was at least one other defining 
feature of HIVAN. The ball-in-cup deposit was most 
commonly associated with C3 positivity. 
The epidemiology of HIVAN reveals a 
strikingly skewed ethnic distribution. Among HIV-
infected individuals, almost all cases of HIVAN 
occur in patients of African descent (19). This 
skewed ethnic prevalence has been confirmed in 
European studies and is not explained by the mode 
of viral transmission (20, 21). Moreover, not all 
African populations seem to have the same 
predisposition to HIVAN. A screening of 126 





Ethiopians who had been HIV infection and 
emigrated to Israel revealed that none of the 
individuals met clinical criteria for HIVAN, as 
defined by proteinuria >2 g/d [22]. Interindividual 
variation, racial differences, and familial clustering 
of kidney disease strongly suggest the existence of 
HIVAN-specific genetic susceptibility factors that 
are unmasked in the setting of HIV infection. 
Although there was an initial suggestion that a 
polymorphism in the promoter of the Duffy 
antigen/receptor for chemokines may be involved in 
susceptibility to HIVAN (23), this has not been 
confirmed in other studies (24). In addition to 
expression of viral genes, a permissive genetic 
background is required for manifestation of the 
HIVAN phenotype (25).  A genome-wide analysis of 
linkage has identified a locus on mouse chromosome 
3A1–3 that influences the HIVAN phenotype 
(named HIVAN1 locus) (25). It is interesting that this 
locus is syntenic to human chromosome 3q25–27, an 
interval that shows suggestive evidence of linkage to 
human diabetic and hypertensive nephropathies (26). 
HIV associated Immune-complex nephropathy 
is associated with advanced HIV disease. ESRD 
incidence is lower in HIV associated Immune 
Complex nephropathy patients compared with those 
with HIVAN. Unlike HIVAN, combined 
antiretroviral therapy use is not associated with the 
incidence of ESRD in Immune complex nephropathy 
(27).  
Findings from light microscopy of kidney 
biopsy tissue are diagnostic in most cases of 
HIVAN. The most common histologic light 
microscopy finding is a collapsing form of focal 
segmental glomerulosclerosis. The glomerular 
capillary tuft is collapsed and may be segmentally or 
globally sclerosed. Visceral epithelial cells are 
hypertrophied and form a characteristic 
pseudocrescent in the Bowman space. 
Tubulointerstitial scarring, atrophy, and marked 
dilatation of the tubules are usually present (28). In 
contrast, Immune complex glomerulonephritis has 
various histological presentations like Mesangial 
proliferative glomerulonephritis, Membranous 
nephropathy, IgA nephropathy, Lupus-like nephritis, 
Membranoproliferative glomerulonephritis, Post-
infectious glomerulonephritis. The majority are of 
Caucasian origin. Deposition of immune complexes 
containing HIV antigens has been occasionally 
demonstrated in renal tissue from patients with 
immune mediated glomerulonephritis suggesting a 
direct viral effect (29). In addition, specific 
implication of co-infection with hepatitis B and C 
virus has also been suggested, mostly for 
mesangioproliferative and membranoproliferative 
glomerulonephritis (30). 
It is important to rule out hepatitis B(HBV) and 
C(HCV) co-infection in patients with immune-
complex glomerulopathy. In some patients co-
infected with HIV and HCV, the development of 
immune complex glomerulonephropathy may 
dominate the clinical course of the disease. The 
occurrence of immune complex 
glomerulonephropathy among black patients at risk 
for HIVAN may be related to the relatively high 
prevalence of HCV infection among intra venous 
drug users in this group (31). The pathogenesis of 
HBV-related kidney disease is hypothesized to 
involve the deposition of HBeAg in glomerular 
capillaries (32). Suppression of HBV replication 
with interferon or lamivudine has been associated 
with remission of kidney disease in some, but not all, 
cases of HBV-related immune complex kidney 
disease (33). 
The case highlights the fact that immune 
mediated glomerulonephritis, although rarer, can be 
the presenting feature of HIV infection. With proper 
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